Godavari Biorefineries Ltd
NSE: GODAVARIB BSE: 544279
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
₹306
52W: ₹186 — ₹354
PE 31 · Book ₹139 · +120% vs bookMarket Cap₹1,564 Cr
Stock P/E31Price to Earnings
ROCE5.5%Return on Capital
ROE0.41%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company has reduced debt.
- +Debtor days have improved from 34.6 to 25.5 days.
Weaknesses
- −The company has delivered a poor sales growth of 5.05% over past five years.
- −Company has a low return on equity of 1.28% over last 3 years.
Shareholding Pattern
Promoters63.31%
FIIs0.98%
DIIs10.39%
Public25.31%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% |
| FIIs | 1.14% | 0.96%▼0.2 | 0.63%▼0.3 | 0.6%▼0.0 | 0.86%▲0.3 | 0.98%▲0.1 |
| DIIs | 14.88% | 14.17%▼0.7 | 13.98%▼0.2 | 11.98%▼2.0 | 11.16%▼0.8 | 10.39%▼0.8 |
| Public | 20.67% | 21.56%▲0.9 | 22.09%▲0.5 | 24.11%▲2.0 | 24.67%▲0.6 | 25.31%▲0.6 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234.23 | 396.58 | 612.53 | 516.16 | 315.94 | 445.37 | 575.7 | 523.12 | 422.81 | 456.88 |
| Expenses | 266.35 | 352.93 | 499.2 | 529.15 | 350.02 | 408.48 | 465.48 | 518.41 | 431.95 | 414.01 |
| Operating Profit | -32.12 | 43.65 | 113.33 | -12.99 | -34.08 | 36.89 | 110.22 | 4.71 | -9.14 | 42.87 |
| OPM % | -13.71% | 11.01% | 18.5% | -2.52% | -10.79% | 8.28% | 19.15% | 0.9% | -2.16% | 9.38% |
| Net Profit | -66.03 | 37.27 | 64.98 | -26.89 | -76.46 | 6.11 | 70.08 | -16.64 | -42.63 | 8.1 |
| EPS ₹ | -15.74 | 8.89 | 15.49 | -6.41 | -18.23 | 1.19 | 13.69 | -3.25 | -8.33 | 1.58 |
AI Insights
Revenue Trend
TTM revenue at ₹1,979Cr, up 6.8% YoY. OPM at 8%.
Debt Position
Borrowings at ₹490Cr. Debt-to-equity ratio: 0.74x. Moderate leverage.
Capex Cycle
CWIP at ₹82Cr (10% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 10.39% (-4.49pp change). FIIs: 0.98% (-0.16pp change). Promoters hold 63.31%.
Margin & Efficiency
ROCE improving from 0% (Mar 2020) to 6% (Mar 2025). Working capital days: 18.
Valuation
PE 31x with 5.5% ROCE. Price is 120% above book value of ₹139. Dividend yield: 0%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d - Earnings Conference Call for Q4 and FY26
- Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Consideration And Approval Of The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 12 May - Board meeting on 22 May 2026 to approve audited Q4 and FY26 results; trading window closed from 1 April 2026.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company states SEBI large-corporate debt framework is not applicable.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 23 Apr - Special Window to re-lodgement of transfer request of physical shares
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr - Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2028 for the quarter 31st March, 2026
- Financial Year 2025 from bse
- Financial Year 2024 from web
- Financial Year 2023 from web